142 related articles for article (PubMed ID: 9279894)
1. Evaluation of genetic stability of recombinant human factor VIII by peptide mapping and on-line mass spectrometric analysis.
Besman MJ; Shiba D
Pharm Res; 1997 Aug; 14(8):1092-8. PubMed ID: 9279894
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry.
Medzihradszky KF; Besman MJ; Burlingame AL
Anal Chem; 1997 Oct; 69(19):3986-94. PubMed ID: 9322435
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII.
Kannicht C; Ramström M; Kohla G; Tiemeyer M; Casademunt E; Walter O; Sandberg H
Thromb Res; 2013 Jan; 131(1):78-88. PubMed ID: 23058466
[TBL] [Abstract][Full Text] [Related]
4. The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.
Casademunt E; Martinelle K; Jernberg M; Winge S; Tiemeyer M; Biesert L; Knaub S; Walter O; Schröder C
Eur J Haematol; 2012 Aug; 89(2):165-76. PubMed ID: 22690791
[TBL] [Abstract][Full Text] [Related]
5. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
6. The manufacturing process of recombinant factor VIII, recombinate.
Gomperts E; Lundblad R; Adamson R
Transfus Med Rev; 1992 Oct; 6(4):247-51. PubMed ID: 1421823
[TBL] [Abstract][Full Text] [Related]
7. Conformational origin of the aggregation of recombinant human factor VIII.
Grillo AO; Edwards KL; Kashi RS; Shipley KM; Hu L; Besman MJ; Middaugh CR
Biochemistry; 2001 Jan; 40(2):586-95. PubMed ID: 11148054
[TBL] [Abstract][Full Text] [Related]
8. [Production of factor VIII by genetic techniques].
Neutzling O
Beitr Infusionsther; 1993; 31():38-43. PubMed ID: 7693262
[TBL] [Abstract][Full Text] [Related]
9. Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids.
Chun BH; Park SY; Chung N; Bang WG
Biotechnol Lett; 2003 Feb; 25(4):315-9. PubMed ID: 12882544
[TBL] [Abstract][Full Text] [Related]
10. Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line.
Winge S; Yderland L; Kannicht C; Hermans P; Adema S; Schmidt T; Gilljam G; Linhult M; Tiemeyer M; Belyanskaya L; Walter O
Protein Expr Purif; 2015 Nov; 115():165-75. PubMed ID: 26318235
[TBL] [Abstract][Full Text] [Related]
11. In vitro stability of recombinant human factor VIII (Recombinate).
Parti R; Ardosa J; Yang L; Mankarious S
Haemophilia; 2000 Sep; 6(5):513-22. PubMed ID: 11012695
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of N-linked oligosaccharide structures of recombinant human factor VIII using fluorophore-assisted carbohydrate electrophoresis.
Kumar HP; Hague C; Haley T; Starr CM; Besman MJ; Lundblad RL; Baker D
Biotechnol Appl Biochem; 1996 Dec; 24(3):207-16. PubMed ID: 8969451
[TBL] [Abstract][Full Text] [Related]
13. Amino acid residues 721-729 are required for full factor VIII activity.
Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
[TBL] [Abstract][Full Text] [Related]
15. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tyrosine sulfate residues in antihemophilic recombinant factor VIII by liquid chromatography electrospray ionization tandem mass spectrometry and amino acid analysis.
Severs JC; Carnine M; Eguizabal H; Mock KK
Rapid Commun Mass Spectrom; 1999; 13(11):1016-23. PubMed ID: 10368977
[TBL] [Abstract][Full Text] [Related]
17. Development of lentiviral vectors for transient and stable protein overexpression in mammalian cells. A new strategy for recombinant human FVIII (rhFVIII) production.
Mufarrege EF; Antuña S; Etcheverrigaray M; Kratje R; Prieto C
Protein Expr Purif; 2014 Mar; 95():50-6. PubMed ID: 24275638
[TBL] [Abstract][Full Text] [Related]
18. Recombinate antihaemophilic factor.
Scoble HA
Dev Biol Stand; 1998; 96():141-7. PubMed ID: 9890528
[No Abstract] [Full Text] [Related]
19. Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate).
Ingerslev J; Christiansen K; Ravn HB; Bray GL; Gomperts ED;
Thromb Haemost; 2002 Apr; 87(4):626-34. PubMed ID: 12008945
[TBL] [Abstract][Full Text] [Related]
20. Characterization of four different mammalian-cell-derived recombinant human interferon-beta 1s. Identical polypeptides and non-identical carbohydrate moieties compared to natural ones.
Utsumi J; Mizuno Y; Hosoi K; Okano K; Sawada R; Kajitani M; Sakai I; Naruto M; Shimizu H
Eur J Biochem; 1989 May; 181(3):545-53. PubMed ID: 2731537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
